RNA — AVIDITY BIOSCIENCES INC

Ownership history in Logos Global Management LP  ·  8 quarters on record

This page tracks every 13F SEC filing in which Logos Global Management LP reported a position in AVIDITY BIOSCIENCES INC (RNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
5.11% (2020 Q2)
Avg. % of fund
2.41%
First filed
2020 Q2
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 500,000 -100,000 -16.7% 2.18% $36.1M —
2025 Q3 REDUCED 600,000 -350,000 -36.8% 2.34% $26.1M —
2025 Q2 ADDED 950,000 +600,000 +171.4% 2.99% $27.0M —
2025 Q1 REDUCED 350,000 -425,000 -54.8% 1.84% $10.3M —
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RNA price (monthly, adj. close)

Other funds also holding RNA

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 15.62% Slotnik Capital, LLC 12.01% Twin Securities, Inc. 3Y 7Y 10.07% Sand Grove Capital Management LLP 3Y 7Y 8.11% HARVEST MANAGEMENT LLC 3Y 7Y 7.61% Slotnik Capital, LLC 6.72% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 6.39% TIG Advisors, LLC 3Y 7Y 6.02% KRYGER CAPITAL Ltd 3Y 5.82% PSquared Asset Management AG 3Y 7Y 5.68%
← Back to Logos Global Management LP Holdings